effect tetrahydroaminoacridin cognit function behaviour alzheim diseas object efficaci tetrahydroaminoacridin tha alzheim diseas design double-blind multipl crossov trial treatment period week activ drug therapi week placebo administr set referral-bas geriatr practic commun hospit patient thirty-four patient moder alzheim diseas subject stage diseas reisberg scale psychotrop drug month consent patient next kin intervent fifti mg tha daili match placebo result initi patient liver toxic gastrointestin side effect studi studi abl minimum dose patient signific effect tha cognit function statu behaviour result individu patient subgroup tha-respons patient conclus tha import benefit alzheim diseas appreci toxic effect 